George McAllister
Hoofd Techniek/Wetenschap/O&O bij Psynova Neurotech Ltd.
Profiel
George McAllister is currently the Head of Research and Development at Psynova Neurotech Ltd.
Prior to this, he worked as the Director of Molecular and Cellular Neuroscience at Merck & Co., Inc. from 1989 to 2006.
He also worked as the Head of Operations at Oxford BioTherapeutics Ltd.
Actieve functies van George McAllister
| Bedrijven | Functie | Begin |
|---|---|---|
Psynova Neurotech Ltd.
 Psynova Neurotech Ltd. BiotechnologyHealth Technology Psynova Neurotech Ltd. provides commercial development and exploitation of novel biomarkers for Neuropsychiatric and other mental illnesses. The company was founded by Sabine Bahn on August 1, 2005 and is headquartered in Cambridge, the United Kingdom. | Hoofd Techniek/Wetenschap/O&O | - |
Eerdere bekende functies van George McAllister
| Bedrijven | Functie | Einde |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01-06-2006 |
Oxford BioTherapeutics Ltd.
 Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Operationeel Directeur | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Psynova Neurotech Ltd.
Psynova Neurotech Ltd. BiotechnologyHealth Technology Psynova Neurotech Ltd. provides commercial development and exploitation of novel biomarkers for Neuropsychiatric and other mental illnesses. The company was founded by Sabine Bahn on August 1, 2005 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Oxford BioTherapeutics Ltd.
Oxford BioTherapeutics Ltd. Pharmaceuticals: MajorHealth Technology Oxford BioTherapeutics Ltd. develops antibody-based medicines for oncology. The firm offers antibody-based cancer drugs with integrated diagnostics against novel targets. The company was founded by Christian Rohlff in 2003 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
